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1. Introduction 
It is generally accepted that for therapeutic use, 
substances such as peptides (and certain drugs) cannot 
be given orally to patients as they will be destroyed 
by the digestive juices. Insulin, for example, can only 
be given effectively by injection because it is degraded 
by proteolytic digestion in the gastro-intestinal tract 
when taken orally. This is a problem for diabetic 
patients who are unable to inject their insulin them- 
selves. Hence there is a need for an effective 
mechanism to allow administration of such proteins 
orally without losing their biological activities. 
Insulin as insulin hydrochloride mixed with a vaso- 
dilator in a tablet form has been successfully 
administered by allowing the tablet o be absorbed 
under the tonque [1]. However in this method the 
long-term effect of large doses of an unphysiological 
concentration of the vasodilator employed is question- 
able. 
The use of liposomes as carriers of therapeutic 
agents uch as enzymes (in enzyme replacement 
therapy), drugs, chelating agents and cell modifying 
compounds has been recently discussed [2]. Lipo- 
somes are spherules formed when phospholipids are 
allowed to swell in aqueous media and they consist 
of concentric closed lipid bilayers alternating with 
aqueous compartments. Within the aqueous phase of 
liposomes, water-insoluble substances can be 
entrapped [3]. We thought hat substances like 
insulin could possibly be administered orally without 
loss of biological activity if protected from the 
digestive juice by encapsulation within liposomes. 
The preliminary experiments reported here 
demonstrate he possibility of oral administration of
insulin by such encapsulation. When liposomes con- 
taining entrapped insulin were given orally to diabetic 
rats, there was a significant reduction of the blood- 
glucose level, whereas the same amount of free 
insulin had no effect on the blood-glucose l vel. 
2. Materials and methods 
Egg phosphatidylcholine (lecithin) was purchased 
from Lipid Products (Epsom); dicetyl phosphate from 
K. and K. Laboratories. Cholesterol and crystalline 
insulin from bovine pancreas were from Sigma. 
Glucose oxidase (Grade I) and horseradish peroxidase 
(Grade I) were obtained from Boehringer and o-dianisidine 
dihydrochloride from BDH. Streptozotocin was a 
gift from Dr K. Rookledge. [12Sl]insulin (5/~Ci/0.1/ag) 
was purchased from Radiochemical Centre, Amersham. 
All other reagents were of analytical grade. 
Liposomes were prepared by dissolving lecithin, 
cholesterol and dicetyl phosphate in a molar ratio of 
10:2:1 in chloroform [4]. The lipid mixture was 
dried on a rotary evaporator at 37°C. Insulin 
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(2.0 mg/ml) suspended in 5 mM phosphate buffer, 
pH 7.2 together with a trace of 12Sl-iodinated insulin 
was allowed to stand for 5 rain and the supernatant 
was added to the dry lipid and gently shaken under N2. 
(A total of 2 mg of insulin was used for each 30 mg 
of lipid). The liposomes thus formed were allowed to 
stand at room temperature for 1 h and then sonicated 
for 1 rain at 4°C using a 19 mm titanium probe at 
1.5 A in an MSE 150W sonicator. The suspension was 
then kept at 4°C for a further hour and then centrifuged 
in an MSE Superspeed 50 centrifuge at 120 O00g for 
3 h. The liposomal pellet was resuspended in the 
phosphate buffer and centrifuged once again as des- 
cribed above. Finally the pellet was suspended in a 
minimum amount of the phosphate buffer and just 
before use was diluted with the buffer to give a final 
concentration of liposomes of 60-70 mg lipid/ml. 
For control experiments liposomes containing no 
insulin were prepared in the absence of the protein 
and this preparation was mixed with insulin solution 
just before use. Percentage entrapment (including 
any possible non-specific associated protein with 
liposomes) [5] was measured by assaying 12Sl.radio. 
activity associated with liposomes in a Wallac "),-counter 
(GTL 300-1000). The percentage of 'total '  entrap- 
ment of insulin varied (from 6 to 26% of the initial 
amount of insulin used) with the batch of insulin and 
from preparation to preparation of liposomes. The 
insulin was not re-assayed but its activity shown here 
was based on that given by Sigma Chemicals Ltd., 
namely 24 IU per mg protein. 
Male and female albino rats (Wistar) were used 
indiscriminately and were made diabetic by intravenous 
injection of streptozotocin (6.5 mg/100 g body wt.) 
[6]. The rats were used within 1-4 weeks after 
streptozotocin jection. They were checked to be 
diabetic by examining the glucose level in their urine. 
The liposomes containing insulin were administered 
to the diabetic or normal rats either orally or 
intraperitoneally. For control experiments, either free 
insulin or insulin + liposomes not containing protein 
(i.e. control iposomes) were similarly administered. 
Blood samples were taken either from the tail or by 
heart puncture before and 3 h after the administration 
of insulin. Blood glucose was determined enzymati- 
cally using glucose oxidase [7,8]. The blood-glucose 
level in the diabetic rats was greater than 400 mg/100 ml 
of blood, and that in normal rats was between 
90-110 mg per 100 ml of blood. 
Table l 
Comparison between the effects of oral and intraperitoneal dministration 
of entrapped or non-entrapped insulin on the blood-glucose l vel of  diabetic rats 
Units of insulin administered 
Orally Intraperitoneally 
5 IU 12 IU 5 IU 12 IU 
Blood-glucose content as % of initial level 
(Mean value ± standard eviation) 
Free insulin 97.5 ± 8.8 85.8 ± 15.4 21.1 ± 5.4 10.6 ± 3.3 
Liposome- 63.4 -+ 14.2 40.7 +_ 16.5 24.0 -+ 6.2 20.7 ± 4.5 
entrapped 
insulin 
Diabetic rats (body weight 175-100  g) were given entrapped or free insulin either 
orally or intraperitoneaily. Each rat received 60-70  mg lipid (as liposomes) in 
1 mi phosphate buffer. Blood samples were taken before and 3 h after insulin 
administration. The results are expressed as the percentage of the initial blood- 
glucose level (i.e. before insulin administration). Five rats were used for oral 
study and three for intraperitoneal injection. 
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3. Results and discussion 
Oral administration of insulin (12 IU) entrapped 
within liposomes reduced the blood-glucose l vel in 
diabetic rats to about one-third of the initial value by 
3 h after administration. These results are comparable 
with those observed when the same amount of entrapped 
insulin was administered intraperitoneally (table 1). 
However the picture is different when the same 
amount of free insulin (12 IU) either alone (table 1) 
or with control iposomes (not shown) is administrated 
orally or intraperitoneally. When given orally to 
diabetic rats, free insulin alone, or insulin given with 
liposomes (but not entrapped), rats failed to reduce 
the blood-glucose l vel by any significant amount and 
the values were not comparable with those obtained 
when the free insulin was administered intraperitone- 
ally (table 1), However the blood-glucose l vel was 
found to decrease to about 50% of the initial value 
if the oral dose of free insulin was increased to 96 
IU. The results show that liposome-entrapped insulin 
retains its activity after being absorbed in the gut, 
whereas free insulin is only effective when administered 
orally in large unphysiological quantities. Thus insulin 
when encapsulated within liposomes is probably pro- 
tected from proteolytic degradation i the gastro- 
intestinal tract. 
Insulin is known to bind to phospholipids under 
certain conditions [9] and could possibly be electro- 
statically associated with the surface of liposomes 
[5] rather than being entrapped within liposomes. 
However the results discussed above discard the 
possibility that insulin is protected from proteolytic 
digestion in the gastrointestinal tract by its non- 
specific association with phospholipid, as free insulin 
mixed with the control iposomes had the same lack 
of effect on the blood-glucose l vel as did free insulin 
alone. 
The effect of insulin on the blood glucose level was 
studied mainly 3 h after its oral administration. The 
results of preliminary experiments indicate that lipo- 
somally entrapped insulin is probably absorbed into 
the circulation within one hour of its oral administra- 
tion. This was judged by the reduced blood-glucose 
level observed within one hour of the oral dose of 
liposome-entrapped insulin. The amount of lipid 
administered orally as liposomes (50-70 mg, containing 
no protein) has no effect on the blood-glucose l vel 
in diabetic rats. 
When 12 IU of liposome-entrapped insulin was 
orally administered to normal rats, no change in the 
blood glucose level was observed (table 2) as com- 
pared with a lowering of blood-glucose when the 
same amount of free insulin was given intraperitone- 
ally. It was moreover observed that in a few rats which 
were previously injected with streptozotocin, but 
whose blood-glucose l vels were not markedly 
elevated (due to unknown reasons), the oral administra- 
tion of 12 IU of liposome-entrapped insulin did not 
reduce their blood-glucose l vel significantly. These 
findings probably suggest that the effective absorp- 
tion of liposome-entrapped protein is possibly 
dependent on the diabetic state of the animals, or the 
amount of the intact insulin absorbed may not be 
sufficient o produce any significant change in the 
blood-glucose l vel in normal rats. These possibilities 
are at present under investigation. 
Experiments are also in progress to obtain more 
satisfactory and reproducible ntrapments of insulin. 
The effect of the low solubility of insulin on 
entrapment and our suspicion that not all the gamma 
(~/) counts are necessarily associated with intact insulin 
is under investigation. The effect of varying lipid com- 
Table 2 
Effects of oral and intraperitoneal dministration of insulin 
on blood-glucose l vel in normal and diabetic rats 
Route of Blood glucose content 
administration % of initial 
in normal in diabetic 
Orally 100.0 42.0 
(Liposome-entrapped 93.6 46.1 
insulin) 114.6 62.4 
97.4 47.9 
Intraperitoneally 29.8 16.5 
(Free insulin) 17.7 24.8 
32.2 20.5 
12 IU of insulin was administered tonormal and diabetic rats 
of body weight 150-170 g. For the oral dose insulin was 
given as liposome-entrapped insulin and for the intraperitoneal 
administration free insulin was used. The blood samples were 
taken before and 3 h after insulin administration. The results 
are expressed as the percentage of the initial blood-glucose 
level. Each result refers to a single rat. 
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position and net charge of the liposomes on their 
possible use in diabetic therapy is also being considered. 
The results discussed here indicate that liposome- 
entrapped insulin, when administered orally, is able 
to reduce the blood-glucose l vel in diabetic rats, 
whereas the same amount of freo insulin administered 
orally has no effect on blood-glucose l vel. The effect 
of liposome-entrapped insulin on blood-glucose l vel 
when administered orally is comparable with that 
produced when it is administered intraperitoneally. 
Our results indicate that by encapsulating insulin 
within liposomes, it is protected from degradation by 
proteolytic digestion in the gastro-intestinal tract, 
and retains its hypoglycemic activity after being 
absorbed in the circulation. Thus liposomes open up a 
new scope for the oral therapeutic use of proteins and, 
probably, other substances which are otherwise not 
suitable for oral administration. 
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